Prema Cognition is a digital healthtech company focused on earlier detection of dementia. It is the company behind PREMAZ, a digital cognitive assessment created in collaboration with the University of Cambridge Memory Lab. PREMAZ is designed to identify subtle changes in cognitive decline long before symptoms appear. By translating advanced neuroscience into a clinician-ready digital tool, Prema Cognition is enabling earlier intervention and supporting research into brain health. The platform is already in use across clinics and research settings in the UK and US. Prema Cognition was co-founded by medical doctor Dr. Julia Cooney, a Forbes 30 Under 30 honoree and Cameron Kirkpatrick.
Prema Cognition
- Health
- Cambridge, United Kingdom
- £550k
- premaz.org
- Update Information
More venture news
- 18 May 2026

Prema CognitionPrema Cognition raises £550k in funding led by SFC Capital for early dementia detection platform
EquityHealth - 14 May 2026

EarswitchEarswitch raises funding led by PXN Ventures for in-ear blood pressure and vital sign monitoring
EquityHealth - 7 May 2026

AsterixAsterix Health raises a £2.1m pre-seed round led by Triple Point for remote GP workforce platform for NHS primary care
Pre-seedHealth
